Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis
Status:
Recruiting
Trial end date:
2023-03-15
Target enrollment:
Participant gender:
Summary
This is a multicentre prospective, randomized, double-blind and imitation, positive-drug
parallel controlled clinical trail. The objective of this study is to evaluate the efficacy
and safety of Huaiqihuang Granule in patients with CKD stage 3 primary glomerulonephritis.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital of Dalian Medical University
Collaborators:
Huazhong University of Science and Technology LinkDoc Technology (Beijing) Co. Ltd.